Human and mouse brain-derived endothelial cells require high levels of growth factors medium for their isolation, in vitro maintenance and survival

Vascular Cell

Eugenio Agostino Parati³  Mark Slevin²  Giulio Alessandri³  Alessandra Bosutti²  Emilio Ciusani¹  Simone Sangiorgi⁵  Sergio Balbi⁵  Silvia Cristini³  Gloria Invernici³  Sara Nava⁴  Giovanni Marfia³  Stefania Elena Navone³ 

[1] Laboratory of Clinical Investigations, IRCCS Foundation Neurological Institute “C. Besta”, Milan, Italy;School of Healthcare Science, Manchester Metropolitan University, Manchester, United Kingdom;Laboratory of Cellular Neurobiology, Cerebrovascular Diseases Unit, IRCCS Foundation Neurological Institute “C. Besta”, via Celoria 11, Milan, 20133, Italy;Unità Produttiva per Terapie Cellulari (UPTC), IRCCS Foundation Neurological Institute “C. Besta”, Milan, Italy;Department of Surgical Sciences, Neurosurgical Unit, University of Insubria, Varese, Italy

关键词: Blood brain barrier;    CD31;    Endothelial junctions;    Endothelial permeability;    Brain microvascular endothelial cells;   

Others  :  801766
DOI  :  10.1186/2045-824X-5-10

 received in 2013-03-27, accepted in 2013-04-30,  发布年份 2013

【 摘 要 】

Background

Brain microvascular endothelial cells (BMVECs) constitute the primary limitation for passage of ions and molecules from the blood into the brain through the blood brain barrier. Numerous multi-step procedures for isolating and culturing BMVECs have been described. However, each one demonstrates major limitations in purity of culture and/or low proliferation rate. Our goal was to study the efficiency of our pending patent medium, Endothelial Proliferation Medium (EndoPM), on the isolation and purification of human and murine BMVECs.

Methods

BMVECs, cultured in EndoPM were compared to those cultured in a commercial medium EBM. Cultures were characterized by flow cytometric analysis, lineage differentiation, the ability to form tube-like structure, immunofluorescence, molecular analyses and also in an in vivo model assay. Moreover permeability was assayed by monitoring the passage of Dextran-FITC through a tight monolayer of BMVECs grown to confluence in Boyden chambers. One way Anova two-tailed test was utilized for all statistical analyses.

Results

The properties of ECs in human and murine BMVECs is confirmed by the expression of endothelial markers (CD31, CD105, CD146, Tie-2 and vWF), of representative proangiogenic genes (ICAM1, VCAM1 and integrin ITGAV), of considerable tube-forming ability, with low-density lipoprotein uptake, eNOS and GLUT-1 expression. Furthermore cells are able to express markers of the junctional architecture as VE-cadherin, β-catenin and Claudin-5 and greatly reduce dextran permeability as barrier functional test. Moreover BMVECs spontaneously organize in vascular-like structures and maintain the expression of endothelial markers in an in vivo xenograft model assay. The significant effect of EndoPM is confirmed by the study of proliferation index, survival index and the behaviour of BMVECs and fibroblasts in co-culture conditions.

Conclusion

Herein we describe a simple and reproducible method for the isolation and expansion of human and mouse BMVECs, based on a newly formulated medium (EndoPM) with optimized concentration of growth factors (EGF, FGF-2 and Bovine Brain Extract-BBE). This procedure should facilitate the isolation and expansion of human and mouse BMVECs with extended lifetime, good viability and purity. This approach may provide an effective strategy to aid phenotypical and functional studies of brain vessels under physiological and pathological conditions.

【 授权许可】

   
2013 Navone et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31.
• [2]Griffioen A, Molema G: Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000, 52:237-268.
• [3]James PB: Pathogenesis of multiple sclerosis: a blood-brain barrier disease. J R Soc Med 1992, 85:713-714.
• [4]Kalaria RN: The blood-brain barrier and cerebral microcirculation in Alzheimer disease. Cerebrovasc Brain Metab Rev 1992, 4:226-260.
• [5]Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ: Structure and function of the blood–brain barrier. Neurobiol Dis 2010, 37:13-25.
• [6]Aird WC: Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds. Cir Res 2007, 100:174-190.
• [7]Drewes L: Molecular architecture of the brain microvasculature. J Mol Neurosci 2001, 16:93-98.
• [8]Bernas MJ, Cardoso FL, Daley SK, Weinand ME, Campos AR, Ferreira AJ, Hoying JB, Witte MH, Brites D, Persidsky Y, Ramirez SH, Brito MA: Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier. Nat Protoc 2010, 5:1265-1272.
• [9]Bowman PD, Betz AL, Ar D, Wolinsky JS, Penney JB, Shivers RR, Goldstein GW: Primary culture of capillary endothelium from rat brain. In Vitro 1981, 17:353-362.
• [10]Bowman PD, Ennis SR, Rarey KE, Betz AL, Goldstein GW: Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability. Ann Neurol 1983, 14:396-402.
• [11]Dorovini-Zis K, Prameya R, Bowman PD: Culture and characterization of microvascular endothelial cells derived from human brain. Lab Invest 1991, 64:425-436.
• [12]Manda KR, Banerjee A, Banks WA, Ercal N: Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood–brain barrier endothelial cells. Free Radical Bio Med 2011, 50:801-810.
• [13]Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO: Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
• [14]Li G, Simon MJ, Cancel LM, Shi ZD, Ji X, Tarbell JM, Morrison B 3rd, Fu BM: Permeability of endothelial and astrocyte cocultures: in vitro blood–brain barrier models for drug delivery studies. Ann Biomed Eng 2010, 38:2499-2511.
• [15]Stannard AK, Bradley NJ, Owen JS: Evaluation of the ECV304 spontaneously transformed HUVEC cell line for adhesion molecule research. Biochem Soc Trans 1997, 25:486S.
• [16]Grammas P, Martinez J, Miller B: Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Re Mol Med 2011, 10:13-19.
• [17]Springhorn JP: Isolation of human capillary endothelial cells using paramagnetic beads conjugated to anti-PECAM antibodies. Cold Spring Harb Protoc 2011, 5:pdb.prot4479.
• [18]Alessandri G, Girelli M, Taccagni G, Colombo A, Nicosia R, Caruso A, Baronio M, Pagano S, Cova L, Parati E: Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab Invest 2001, 81:875-885.
• [19]Chaoyu M, Xiao-Fan W: In Vitro Assays for the Extracellular Matrix Protein-Regulated Extravasation Process. Cold Spring Harb Protoc 2008, 3:pdb.prot5034.
• [20]Sano Y, Kanda T: Isolation and properties of endothelial cells forming the blood-nerve barrier. Methods Mol Biol 2011, 686:417-425.
• [21]Bachetti T, Morbidelli L: Endothelial cells in culture: a model for studying vascular functions. Pharmacol Res 2000, 42:9-19.
• [22]Kamiichi A, Furihata T, Kishida S, Ohta Y, Saito K, Kawamatsu S, Chiba K: Establishment of a new conditionally immortalized cell line from human brain microvascular endothelial cells: a promising tool for human blood–brain barrier studies. Brain Res 2012, 1488:113-122.
• [23]Invernici G, Ponti D, Corsini E, Cristini S, Frigerio S, Colombo A, Parati E, Alessandri G: Human microvascular endothelial cells from different fetal organs demonstrate organ-specific CAM expression. Exp Cell Res 2005, 308:273-282.
• [24]Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828.
• [25]van Beijnum JR, Rousch M, Castermans K, van der Linden E, Griffioen AW: Isolation of endothelial cells from fresh tissues. Nat Protoc 2008, 3:1085-1091.
• [26]McAuslan BR, Hannan GN, Reilly W: Signals causing change in morphological phenotype, growth mode, and gene expression of vascular endothelial cells. J Cell Physiol 1982, 112:96-106.
• [27]Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
• [28]Pardridge WM, Boado RJ, Farrell CR: Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem 1990, 265:18035-18040.
• [29]Chan GN, Bendayan R: Molecular and functional characterization of p-glycoprotein in vitro. Methods Mol Biol 2011, 686:313-336.
• [30]Male DK: Expression and induction of p-glycoprotein-1 on cultured human brain endothelium. J Cereb Blood Flow Metab 2009, 29:1760-1763.
• [31]Bazzoni G, Dejana E: Endothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis. Physiol Rev 2004, 84:869-901.
• [32]Abbott NJ, Rönnbäck L, Hansson E: Astrocyte–endothelial interactions at the blood–brain barrier. Nature Review 2006, 7:41-53.